Clinical Trials Directory

Trials / Conditions / MGMT-Methylated Glioblastoma

MGMT-Methylated Glioblastoma

7 registered clinical trials studyying MGMT-Methylated Glioblastoma — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingRuxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Gliobla
NCT06991101
Baptist Health South FloridaPhase 2
RecruitingG-CSF After Chemo-radiation in Patients With Glioblastoma
NCT06649851
Massachusetts General HospitalPhase 2
RecruitingLomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
NCT06419946
Vastra Gotaland RegionPhase 3
RecruitingDB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma
NCT06504381
University of California, San FranciscoPhase 1 / Phase 2
SuspendedTesting the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for
NCT05432804
National Cancer Institute (NCI)Phase 1 / Phase 2
Withdrawn6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)
NCT04926168
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins—
CompletedRegorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients
NCT06095375
Istituto Oncologico Veneto IRCCSPhase 1